Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
RM

RMD

Market Closed

ResMed Inc.

NYSEHealthcareMedical - Instruments & Supplies
US
11.37K employees
CEO: Michael J. Farrell
Founded: 1995
$235.74
+$0.00(+NaN%)
Market Cap
33.16B
Beta
0.76
52W Range
N/A
Dividend Yield
1.04%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: ResMed’s current price trades 30.4% below its high-confidence fair value estimate of $307.38, indicating potential undervaluation. Financial health scores are excellent except for low growth (1/5), while Monte Carlo shows high volatility (CV 90.89%) and 36.1% downside risk below current price. Valuation methods and scenarios reveal wide outcome dispersion, signaling substantial opportunity tempered by notable risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore RMD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

RMD in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →